|
1
|
García-Solares J, Donnez J, Donnez O and
Dolmans MM: Pathogenesis of uterine adenomyosis: Invagination or
metaplasia? Fertil Steril. 109:371–379. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bazot M and Daraï E: Role of transvaginal
sonography and magnetic resonance imaging in the diagnosis of
uterine adenomyosis. Fertil Steril. 109:389–397. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Leyendecker G, Wildt L and Mall G: The
pathophysiology of endometriosis and adenomyosis: Tissue injury and
repair. Arch Gynecol Obstet. 280:529–538. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pontis A, D'Alterio MN, Pirarba S, de
Angelis C, Tinelli R and Angioni S: Adenomyosis: A systematic
review of medical treatment. Gynecol Endocrinol. 32:696–700.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Spitz IM: Clinical utility of progesterone
receptor modulators and their effect on the endometrium. Curr Opin
Obstet Gynecol. 21:318–24. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Badawy AM, Elnashar AM and Mosbah AA:
Aromatase inhibitors or gonadotropin-releasing hormone agonists for
the management of uterine adenomyosis: A randomized controlled
trial. Acta Obstet Gynecol Scand. 91:489–495. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fawzy M and Mesbah Y: Comparison of
dienogest versus triptorelin acetate in premenopausal women with
adenomyosis: A prospective clinical trial. Arch Gynecol Obstet.
292:1267–1271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vigano P, Corti L and Berlanda N: Beyond
infertility: Obstetrical and postpartum complications associated
with endometriosis and adenomyosis. Fertil Steril. 104:802–812.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Huang TS, Chen YJ, Chou TY, Chen CY, Li
HY, Huang BS, Tsai HW, Lan HY, Chang CH, Twu NF, et al:
Oestrogen-induced angiogenesis promotes adenomyosis by activating
the Slug-VEGF axis in endometrial epithelial cells. J Cell Mol Med.
18:1358–1371. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Marjoribanks J, Ayeleke RO, Farquhar C and
Proctor M: Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
Cochrane Database Syst Rev: CD001751, 2015.
|
|
11
|
Lethaby A, Duckitt K and Farquhar C:
Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.
Cochrane Database Syst Rev: CD000400, 2013.
|
|
12
|
Navone SE, Guarnaccia L, Cordiglieri C,
Crisà FM, Caroli M, Locatelli M, Schisano L, Rampini P, Miozzo M,
La Verde N, et al: Aspirin affects tumor angiogenesis and
sensitizes human glioblastoma endothelial cells to temozolomide,
bevacizumab, and sunitinib, impairing vascular endothelial growth
factor-related signaling. World Neurosurg. 120:e380–e391.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang L, Li S, Li L, Chen Z and Yang Y:
COX2 inhibition in the endothelium induces glucose metabolism
normalization and impairs tumor progression. Mol Med Rep.
17:2937–2944. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hu W, Pei H, Sun F, Li P, Nie J, Li B, Hei
TK and Zhou G: Epithelial-mesenchymal transition in non-targeted
lung tissues of Kunming mice exposed to X-rays is suppressed by
celecoxib. J Radiat Res. 59:583–587. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gungor H, Ilhan N and Eroksuz H: The
effectiveness of cyclooxygenase-2 inhibitors and evaluation of
angiogenesis in the model of experimental colorectal cancer. Biomed
Pharmacother. 102:221–229. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sauer CM, Myran DT, Costentin CE, Zwisler
G, Safder T, Papatheodorou S and Mucci LA: Effect of long term
aspirin use on the incidence of prostate cancer: A systematic
review and meta-analysis. Crit Rev Oncol Hematol. 132:66–75.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gao F, Zafar MI, Jüttner S, Höcker M and
Wiedenmann B: Expression and molecular regulation of the Cox2 gene
in gastroenteropancreatic neuroendocrine tumors and
antiproliferation of nonsteroidal anti-inflammatory drugs (NSAIDs).
Med Sci Monit. 24:8125–8140. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li J, Hao Q, Cao W, Vadgama JV and Wu Y:
Celecoxib in breast cancer prevention and therapy. Cancer Manag
Res. 10:4653–4667. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guo CG and Leung WK: Potential strategies
in the prevention of nonsteroidal anti-inflammatory
drugs-associated adverse effects in the lower gastrointestinal
tract. Gut Liver 2019 (Epub ahead of print).
|
|
20
|
Monteiro B and Steagall PV:
Antiinflammatory drugs. Vet Clin North Am Small Anim Pract.
49:993–1011. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Melcarne L, García-Iglesias P and Calvet
X: Management of NSAID-associated peptic ulcer disease. Expert Rev
Gastroenterol Hepatol. 10:723–733. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Granstrom DE: Agricultural (nonbiomedical)
animal research outside the laboratory: A review of guidelines for
institutional animal care and use committees. ILAR J. 44:206–210.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shen M, Liu X, Zhang H and Guo SW:
Transforming growth factor β1 signaling coincides with
epithelial-mesenchymal transition and fibroblast-to-myofibroblast
transdifferentiation in the development of adenomyosis in mice. Hum
Reprod. 31:355–369. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhu B, Chen Y, Zhang H, Liu X and Guo SW:
Resveratrol reduces myometrial infiltration, uterine hyperactivity,
and stress levels and alleviates generalized hyperalgesia in mice
with induced adenomyosis. Reprod Sci. 22:1336–1349. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jin Z, Wang L and Zhu Z: Effect of
GuiXiong Xiaoyi Wan in treatment of endometriosis on rats. Evid
Based Complement Alternat Med. 2015(208514)2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ding D, Liu X, Duan J and Guo SW:
Platelets are an unindicted culprit in the development of
endometriosis: Clinical and experimental evidence. Hum Reprod.
30:812–832. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bird CC, McElin TW and Manalo-Estrella P:
The elusive adenomyosis of the uterus-revisited. Am J Obstet
Gynecol. 112:583–593. 1972.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Plone MA, Emerich DF and Lindner MD:
Individual differences in the hotplate test and effects of
habituation on sensitivity to morphine. Pain. 66:265–270.
1996.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bjarnason I, Scarpignato C, Holmgren E,
Olszewski M, Rainsford KD and Lanas A: Mechanisms of damage to the
gastrointestinal tract from nonsteroidal anti-inflammatory drugs.
Gastroenterology. 154:500–514. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Parente L and Perretti M: Advances in the
pathophysiology of constitutive and inducible cyclooxygenases: Two
enzymes in the spotlight. Biochem Pharmacol. 65:153–159.
2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ota H, Igarashi S, Sasaki M and Tanaka T:
Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium
in endometriosis and adenomyosis. Hum Reprod. 16:561–566.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang Y, Qu Y and Song W: Genetic variation
in COX-2-1195 and the risk of endometriosis and adenomyosis. Clin
Exp Obstet Gynecol. 42:168–172. 2015.PubMed/NCBI
|
|
33
|
Maia HJ Jr, Haddad C, Pinheiro N and Casoy
J: The effect of oral contraceptives on aromatase and Cox-2
expression in the endometrium of patients with idiopathic
menorrhagia or adenomyosis. Int J Womens Health. 5:293–299.
2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Manna PR, Molehin D and Ahmed AU:
Dysregulation of aromatase in breast, endometrial, and ovarian
cancers: An overview of therapeutic strategies. Prog Mol Biol
Transl Sci. 144:487–537. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen YJ, Li HY, Huang CH, Twu NF, Yen MS,
Wang PH, Chou TY, Liu YN, Chao KC and Yang MH: Oestrogen-induced
epithelial-mesenchymal transition of endometrial epithelial cells
contributes to the development of adenomyosis. J Pathol.
222:261–270. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Khan KN, Kitajima M, Hiraki K, Fujishita
A, Nakashima M and Masuzaki H: Involvement of hepatocyte growth
factor-induced epithelial-mesenchymal transition in human
adenomyosis. Biol Reprod. 92(35)2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bilyk O, Coatham M, Jewer M and Postovit
LM: Epithelial-to-mesenchymal transition in the female reproductive
tract: From normal functioning to disease pathology. Front Oncol.
7(145)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tsui KH, Lee WL, Chen CY, Sheu BC, Yen MS,
Chang TC and Wang PH: Medical treatment for adenomyosis and/or
adenomyoma. Taiwan J Obstet Gynecol. 53:459–465. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chamoun-Emanuelli AM, Bryan LK, Cohen ND,
Tetrault TL, Szule JA, Barhoumi R and Whitfield-Cargile CM: NSAIDs
disrupt intestinal homeostasis by suppressing macroautophagy in
intestinal epithelial cells. Sci Rep. 9(14534)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lands LC and Stanojevic S: Oral
non-steroidal anti-inflammatory drug therapy for lung disease in
cystic fibrosis. Cochrane Database Syst Rev.
9(CD001505)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Vallée A, Lecarpentier Y and Vallée JN:
Targeting the canonical WNT/β-catenin pathway in cancer treatment
using non-steroidal anti-inflammatory drugs. Cells.
8(E726)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rižner TL: The important roles of steroid
sulfatase and sulfotransferases in gynecological diseases. Front
Pharmacol. 7(30)2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Urabe M, Yamamoto T, Kitawaki J, Honjo H
and Okada H: Estrogen biosynthesis in human uterine adenomyosis.
Acta Endocrinol (Copenh). 121:259–264. 1989.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Benagiano G and Brosens I: The endometrium
in adenomyosis. Womens Health (Lond). 8:301–312. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kitawaki J, Noguchi T, Amatsu T, Maeda K,
Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y and Honjo H: Expression
of aromatase cytochrome P450 protein and messenger ribonucleic acid
in human endometriotic and adenomyotic tissues but not in normal
endometrium. Biol Reprod. 57:514–519. 1997.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kitawaki J, Koshiba H, Ishihara H, Kusuki
I, Tsukamoto K and Honjo H: Progesterone induction of
17beta-hydroxysteroid dehydrogenase type 2 during the secretory
phase occurs in the endometrium of estrogen-dependent benign
diseases but not in normal endometrium. J Clin Endocrinol Metab.
85:3292–3296. 2000.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Liu X, Shen M, Qi Q, Zhang H and Guo SW:
Corroborating evidence for platelet-induced epithelial-mesenchymal
transition and fibroblast-to-myofibroblast transdifferentiation in
the development of adenomyosis. Hum Reprod. 31:734–749.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Manta L, Suciu N, Toader O, Purcărea RM,
Constantin A and Popa F: The etiopathogenesis of uterine
fibromatosis. J Med Life. 9:39–45. 2016.PubMed/NCBI
|
|
50
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Hinz B: Formation and function of the
myofibroblast during tissue repair. J Invest Dermatol. 127:526–537.
2007.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Thannickal VJ, Zhou Y, Gaggar A and Duncan
SR: Fibrosis: Ultimate and proximate causes. J Clin Invest.
124:4673–4677. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tai Y, Zhang LH, Gao JH, Zhao C, Tong H,
Ye C, Huang ZY, Liu R and Tang CW: Suppressing growth and invasion
of human hepatocellular carcinoma cells by celecoxib through
inhibition of cyclooxygenase-2. Cancer Manag Res. 11:2831–2848.
2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Saxena P, Sharma PK and Purohit P: A
journey of celecoxib from pain to cancer. Prostaglandins Other
Lipid Mediat. 147(106379)2019.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
